Lecture Notes, Biology 203, Human Sexuality and Reproduction
Hormones, Part 2
- Hormones in Older Adults
- Men
- By age 45, testosterone is being maintained at a lower level, with various consequences
- Decreased sperm count (not necessarily enough to make the man less fertile)
- Decreased sexual desire
- Decreased frequency of erections/ejaculations
- Decreased sexual performance
- Men may become alarmed or depressed, but can continue to have an active sex life if they (and their sexual partners) can be patient with themselves
- For severe cases, psychological counseling may help, occasionally testosterone treatment may be helpful
- Women
- After age 30-35, set point for maximum monthly estrogen level starts to fall
- Between ages 42 and 55 (average 50), the aging ovary stops responding to LH/FSH from pituitary, resulting in menopause (cessation of menstruation)
- Resulting decrease in E production prevents negative feedback from suppressing LH/FSH levels, so levels of LH/FSH rise in perimenopausal women
- Decrease in E is responsible for most of the symptoms associated with menopause
- Reversal of some sexual characteristics occurs (body shape, changes in breasts, hips, fat distribution, decreased vaginal lubrication)
- Changes in regulation of circulatory system may result in hot flashes, night sweats, headaches
- Decrease in E also decreases level of HDL and allows LDL to rise, increasing risk of cardiovascular disease
- Decrease in E increases likelihood of osteoporosis
- E enhances ability to use calcium, so when E level falls, bones may lose calcium, become brittle and easily broken
- In smokers, decrease in E occurs sooner, so earlier decrease in calcium absorption
- Hormone replacement therapy (includes both E and P to avoid slight increase in risk of uterine cancer if E is given alone)
- Reduces risk of heart attack, stroke, Alzheimer's in some studies, but not in others
- No increase in risk of breast cancer until woman has had more than 10 years of HRT
- Slight increase in breast cancer at that point suggests that women who have family history of breast cancer should not continue HRT for that long